Corient Capital Partners’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.41M Hold
33,130
0.11% 165
2022
Q2
$1.41M Buy
33,130
+6,520
+25% +$310K 0.11% 174
2022
Q1
$1.43M Sell
26,610
-1,390
-5% -$80.9K 0.09% 186
2021
Q4
$2.01M Buy
28,000
+250
+0.9% +$15.7K 0.13% 147
2021
Q3
$1.58M Buy
27,750
+510
+2% +$31K 0.12% 166
2021
Q2
$1.77M Buy
27,240
+1,790
+7% +$113K 0.13% 148
2021
Q1
$1.51M Buy
25,450
+1,820
+8% +$99.2K 0.13% 144
2020
Q4
$1.12M Sell
23,630
-7,260
-24% -$305K 0.11% 168
2020
Q3
$1.02M Sell
30,890
-4,430
-13% -$153K 0.12% 159
2020
Q2
$1.14M Sell
35,320
-2,180
-6% -$59.5K 0.14% 140
2020
Q1
$900K Sell
37,500
-9,140
-20% -$263K 0.14% 134
2019
Q4
$1.36M Buy
46,640
+26,050
+127% +$692K 0.17% 131
2019
Q3
$476K Buy
20,590
+2,140
+12% +$44.9K 0.07% 272
2019
Q2
$347K Sell
18,450
-69,620
-79% -$1.32M 0.05% 284
2019
Q1
$1.58M Buy
+88,070
New +$1.47M 0.26% 111

Other funds holding LRCX

Corient Capital Partners's LRCX Position: Q3 2022 in Review

Corient Capital Partners held its Lam Research (LRCX) position steady in Q3 2022 at 33,130 shares worth $1.41M. The position accounts for 0.11% of the portfolio, ranked #165.

Corient Capital Partners first reported a position in LRCX in Q1 2019 and has held it in 15 quarters since. The position peaked at $2.01M in Q4 2021. 1,271 funds tracked by Wall St. Rank hold LRCX as of Q3 2022.

  • Corient Capital Partners held 33,130 shares of Lam Research worth $1.41M as of Q3 2022.
  • Corient Capital Partners left its Lam Research share count unchanged in Q3 2022.
  • Lam Research made up 0.11% of Corient Capital Partners's portfolio in Q3 2022, its #165 holding.
  • Corient Capital Partners first reported a position in Lam Research in Q1 2019 and has held it in 15 quarters since.
  • Corient Capital Partners's Lam Research position peaked at $2.01M in Q4 2021.
  • 1,271 funds tracked by Wall St. Rank held Lam Research as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.